The prevalence and predictors of herb-drug interactions among Iranian cancer patients during chemotherapy courses

[21] Loong L(2018)Why people use herbal medicine: insights from a focus-group study in Germany BMC Complement Altern Med 18 1-152

[22] Greener M(2012)An overview of the evidence and mechanisms of herb–drug interactions Front Pharmacol 3 69-912

[23] Asiimwe JB(2019)Herb-drug interactions and hepatotoxicity Curr Drug Metab 20 275-310

[24] Nagendrappa PB(2013)Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs Br J Cancer 108 1071-2685

[25] Atukunda EC(2009)Identification and exploration of herb-drug combinations used by cancer patients Integr Cancer Ther 8 29-137

[26] Kamatenesi MM(2006)Inhibitory effects of the essential oil of chamomile (Matricaria recutita L.) and its major constituents on human cytochrome P450 enzymes Life Sci 78 856-54

[27] Nambozi G(2019)Adverse event reporting patterns of concomitant botanical dietary supplements with CYP3A4 interactive & CYP3A4 non-interactive anticancer drugs in the US Food and Drug Administration Adverse Event Reporting System (FAERS) Expert Opin Drug Saf 18 145-53

[28] Tolo CU(2009)In vitro inhibition of CYP3A4 by herbal remedies frequently used by cancer patients Phytother Res 23 906-4

[29] Ong’udi M(2017)Potential drug interactions with dietary and herbal supplements during hospitalization Intern Emerg Med 12 301-e717

[30] Mutai P(2020)Potential herb–drug interactions in community-dwelling older adults in China: the Shanghai Aging Study Aging Clin Exp Res 32 2677-116

[21] Loong L(2018)Why people use herbal medicine: insights from a focus-group study in Germany BMC Complement Altern Med 18 1-152

[22] Greener M(2012)An overview of the evidence and mechanisms of herb–drug interactions Front Pharmacol 3 69-912

[23] Asiimwe JB(2019)Herb-drug interactions and hepatotoxicity Curr Drug Metab 20 275-310

[24] Nagendrappa PB(2013)Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs Br J Cancer 108 1071-2685

[25] Atukunda EC(2009)Identification and exploration of herb-drug combinations used by cancer patients Integr Cancer Ther 8 29-137

[26] Kamatenesi MM(2006)Inhibitory effects of the essential oil of chamomile (Matricaria recutita L.) and its major constituents on human cytochrome P450 enzymes Life Sci 78 856-54

[27] Nambozi G(2019)Adverse event reporting patterns of concomitant botanical dietary supplements with CYP3A4 interactive & CYP3A4 non-interactive anticancer drugs in the US Food and Drug Administration Adverse Event Reporting System (FAERS) Expert Opin Drug Saf 18 145-53

[28] Tolo CU(2009)In vitro inhibition of CYP3A4 by herbal remedies frequently used by cancer patients Phytother Res 23 906-4

[29] Ong’udi M(2017)Potential drug interactions with dietary and herbal supplements during hospitalization Intern Emerg Med 12 301-e717

[30] Mutai P(2020)Potential herb–drug interactions in community-dwelling older adults in China: the Shanghai Aging Study Aging Clin Exp Res 32 2677-116